Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

cans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate floor." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CO Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

cans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate floor." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CQ Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

cans brushing aside complaints from immigrant-rights groups to power the nomination to the Senate floor." The 6-3 vote in the Homeland Security and Governmental Affairs Committee sets up a full floor vote as early as next week. CQ Roll Call (9/30, Misra, 154K) reports that at his confirmation hearing last week, Wolf "faced